News
04-15-2014, 06:12 AM
Eventus Diagnostics, Inc. today announced completion of a $2.72 million financing. The financing was led by a new family office private investor, and existing investors also participated. Proceeds of the financing will mostly be used to support the continued development and commercialization of the company's Octava breast cancer tests.
More... (http://www.news-medical.net/news/20140415/EventusDx-completes-24272M-financing-to-support-development-commercialization-of-Octava-breast-cancer-tests.aspx)
More... (http://www.news-medical.net/news/20140415/EventusDx-completes-24272M-financing-to-support-development-commercialization-of-Octava-breast-cancer-tests.aspx)